Medical School · Year 2 · Msk Dermatology · includes a quiz and discussion video

Lecture 02: Osteoarthritis

Unit 2.10: Musculoskeletal and Dermatology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the epidemiology and risk factors for osteoarthritis
2. Explain the pathophysiology of cartilage degeneration
3. Describe the clinical features and diagnosis of osteoarthritis
4. Explain the radiographic findings in osteoarthritis
5. Describe the management of osteoarthritis
6. Explain the indications for surgical intervention

Lecture Outline

I. Overview and Epidemiology of Osteoarthritis

Osteoarthritis represents a degenerative joint disease characterized by progressive loss of articular cartilage accompanied by secondary changes in subchondral bone, synovium, and periarticular structures. The condition is classified as primary (idiopathic) when no identifiable underlying cause exists, or secondary when attributable to a specific predisposing condition such as prior trauma, congenital joint abnormalities, inflammatory arthritis, or metabolic disorders. The pathological process is progressive and currently irreversible, though the rate of progression varies considerably among individuals and affected joints. Understanding osteoarthritis as a disease of the entire joint organ rather than merely cartilage degeneration has important implications for therapeutic approaches.

Osteoarthritis constitutes the most prevalent form of arthritis worldwide, affecting over 30 million adults in the United States alone and representing a leading cause of disability in elderly populations. The prevalence increases dramatically with age, with radiographic evidence present in more than 80% of individuals over age 75, though symptomatic disease is less common. Before age 50, men have higher prevalence than women, but this pattern reverses in older age groups, with women demonstrating higher rates particularly of hand and knee osteoarthritis. The economic burden is substantial, encompassing both direct healthcare costs and indirect costs from lost productivity and disability.

Risk factors for osteoarthritis development encompass non-modifiable characteristics and potentially modifiable conditions that offer opportunities for prevention. Non-modifiable factors include advancing age (the strongest risk factor), female sex particularly after menopause, and genetic predisposition with heritability estimates of 40-65% for hand and hip osteoarthritis. Modifiable risk factors include obesity, which increases risk for knee osteoarthritis through both mechanical loading and systemic inflammatory effects of adipose tissue. Prior joint injury, including anterior cruciate ligament tears, meniscal damage, and fractures involving articular surfaces, substantially increases subsequent osteoarthritis risk. Occupational factors involving repetitive joint loading, such as kneeling, squatting, or heavy lifting, contribute to site-specific osteoarthritis.

The distinction between primary and secondary osteoarthritis carries implications for evaluation and management. Primary osteoarthritis typically develops insidiously in middle-aged or elderly individuals without identifiable precipitating events, often affecting characteristic joint distributions. Secondary osteoarthritis may present at younger ages or in atypical distributions, warranting investigation for underlying conditions. Important secondary causes include post-traumatic arthritis following joint injuries, avascular necrosis from disrupted blood supply to subchondral bone, hemochromatosis causing iron deposition in joints, Wilson disease with copper accumulation, acromegaly from growth hormone excess, and prior inflammatory or infectious arthritis. Identification of secondary causes may permit treatment of the underlying condition and inform prognosis.

<image>Panel A: Bar graph demonstrating increasing osteoarthritis prevalence by age decade for men and women, showing the reversal of sex predominance after age 50 with women having higher rates. Panel B: Diagram of modifiable and non-modifiable risk factors for osteoarthritis, with obesity, prior injury, and occupational factors shown as modifiable and age, sex, and genetics as non-modifiable. Panel C: Body diagram showing typical joint distribution in primary osteoarthritis affecting hands (DIP, PIP, first CMC), knees, hips, and spine, with relative frequencies indicated. Panel D: Comparison of primary versus secondary osteoarthritis features with examples of secondary causes including trauma, metabolic disorders, and prior inflammatory disease.</image>

II. Pathophysiology of Cartilage Degeneration

The pathophysiology of osteoarthritis involves a complex cascade of molecular and cellular events ultimately resulting in cartilage breakdown, though the process begins long before clinical symptoms or radiographic changes become apparent. Early changes include proteoglycan loss from the cartilage matrix, with consequent increase in water content as the collagen network expands to accommodate osmotic swelling in the absence of proteoglycan-mediated restraint. Progressive disruption of the collagen network follows, with cleavage of type II collagen fibrils that compromises the structural integrity essential for resisting tensile and shear forces. Surface fibrillation develops as the superficial cartilage layer becomes irregular, eventually progressing to fissures extending into deeper zones and ultimately full-thickness erosion exposing subchondral bone.

Subchondral bone undergoes characteristic changes that both reflect and contribute to disease progression. Increased mechanical stress transmitted through thinning cartilage stimulates bone remodeling, resulting in subchondral sclerosis with increased bone density directly beneath eroded cartilage. Osteophytes form at joint margins through endochondral ossification, representing attempted repair or joint stabilization but potentially restricting motion and causing impingement. Subchondral cysts or geodes develop through intrusion of synovial fluid through cartilage defects into subchondral bone, or alternatively through focal bone necrosis from microfractures. These bony changes progress even as cartilage destruction continues, contributing to the irreversibility of established disease.

Although historically considered a non-inflammatory degenerative condition, contemporary understanding recognizes synovial inflammation as a significant contributor to osteoarthritis pathophysiology. The synovium produces pro-inflammatory cytokines including interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) that promote cartilage degradation. Synovial effusion develops, though typically mild and non-inflammatory with white blood cell counts below 2000 per microliter, distinguishing osteoarthritis from inflammatory arthropathies. Cartilage breakdown products released into the joint space activate synovial macrophages, perpetuating a cycle of inflammation and degradation. This inflammatory component provides rationale for anti-inflammatory treatments and identifies potential targets for disease modification.

At the molecular level, cartilage destruction results from imbalance between catabolic processes that degrade matrix components and anabolic processes that attempt matrix repair. Matrix metalloproteinases (MMPs), particularly collagenases (MMP-1, MMP-13) and aggrecanases (ADAMTS-4, ADAMTS-5), directly cleave collagen and proteoglycan molecules. Chondrocytes, responding to mechanical stress and inflammatory signals, paradoxically contribute to matrix destruction by upregulating catabolic enzyme expression while simultaneously attempting reparative synthesis. Chondrocyte death through apoptosis further diminishes repair capacity. The insufficient anabolic response fails to compensate for ongoing degradation, resulting in progressive matrix loss.

<image>Panel A: Sequential histological representation of cartilage degeneration stages from normal cartilage through proteoglycan depletion, surface fibrillation, fissuring, and full-thickness erosion with exposed subchondral bone. Panel B: Diagram showing subchondral bone changes including sclerosis beneath eroded cartilage, marginal osteophyte formation through endochondral ossification, and subchondral cyst development. Panel C: Molecular pathway diagram showing pro-inflammatory cytokines (IL-1, TNF-alpha) inducing MMP and ADAMTS expression in chondrocytes, leading to collagen and proteoglycan degradation. Panel D: Illustration of the imbalance between catabolic factors (MMPs, cytokines, mechanical stress) and anabolic factors (growth factors, matrix synthesis) in osteoarthritic cartilage with a scale metaphor showing catabolic predominance.</image>

III. Clinical Features and Presentation

The cardinal symptom of osteoarthritis is joint pain that characteristically worsens with activity and improves with rest, distinguishing it from inflammatory arthritis where pain and stiffness may be worse after periods of inactivity. Pain initially occurs during or after joint use, but as disease progresses may become constant and even disturb sleep. Patients typically describe deep, aching discomfort localized to the affected joint, though referred pain patterns may complicate localization, particularly with hip osteoarthritis presenting as groin, thigh, or knee pain. Pain severity correlates imperfectly with radiographic changes, as substantial cartilage loss may occur with minimal symptoms in some individuals while others experience significant pain with relatively mild structural changes.

Morning stiffness represents another characteristic symptom, though its duration distinguishes osteoarthritis from inflammatory arthropathies. In osteoarthritis, morning stiffness typically lasts less than 30 minutes, reflecting inactivity-related gelling that resolves with movement. By contrast, rheumatoid arthritis and other inflammatory conditions typically produce morning stiffness exceeding 60 minutes. Patients also experience stiffness after sitting or other periods of immobility, termed the "gelling phenomenon," which similarly improves with activity. Range of motion progressively decreases as osteophytes, capsular contracture, and muscle guarding limit joint excursion. Functional impairment follows, with difficulty performing activities of daily living including walking, climbing stairs, rising from chairs, and gripping objects.

Physical examination findings reflect the underlying structural changes and inflammatory component of osteoarthritis. Bony enlargement from osteophytes is palpable at joint margins, particularly evident at the distal interphalangeal joints (Heberden nodes) and proximal interphalangeal joints (Bouchard nodes) of the hands. Crepitus, a grinding or crackling sensation palpable during joint movement, results from irregular articular surfaces and loose bodies. Joint line tenderness indicates synovial irritation and subchondral pathology. Mild effusion may be present, though massive effusions suggest superimposed conditions such as crystal arthropathy or septic arthritis. Malalignment develops in advanced disease, with varus (bow-legged) deformity common in knee osteoarthritis. Muscle weakness and atrophy from disuse accompany chronic joint disease.

The distribution of joint involvement in primary osteoarthritis follows characteristic patterns that aid in diagnosis and differentiation from other arthropathies. The knee is the most commonly affected large joint, with involvement of medial, lateral, and patellofemoral compartments variably affected. Hip osteoarthritis presents with groin pain, limp, and restricted internal rotation. Hand osteoarthritis characteristically involves the distal interphalangeal, proximal interphalangeal, and first carpometacarpal joints, with the squared appearance of the thumb base being particularly distinctive. The spine is affected in both cervical and lumbar regions, with facet joint osteoarthritis potentially contributing to spinal stenosis. Notably, certain joints including the metacarpophalangeal joints, wrists, ankles, and shoulders are typically spared in primary osteoarthritis, and involvement of these sites should prompt consideration of secondary causes.

<image>Panel A: Photograph of hand osteoarthritis showing Heberden nodes at the DIP joints and Bouchard nodes at the PIP joints, with the characteristic squared appearance of the first CMC joint. Panel B: Clinical photograph of a knee demonstrating varus (bow-legged) deformity with visible bony enlargement and slight effusion. Panel C: Diagram illustrating the pattern of joint involvement in primary osteoarthritis with affected joints highlighted (DIPs, PIPs, first CMC, knees, hips, spine) versus typically spared joints (MCPs, wrists, ankles, shoulders). Panel D: Examination techniques showing palpation of joint line tenderness, assessment of crepitus with range of motion, and ballottement for effusion at the knee.</image>

IV. Diagnosis and Diagnostic Criteria

The diagnosis of osteoarthritis is primarily clinical, based on characteristic history, physical examination findings, and supportive imaging, without requirement for laboratory confirmation. The American College of Rheumatology has established classification criteria for knee osteoarthritis that include age 50 years or older, morning stiffness lasting less than 30 minutes, crepitus on active motion, bony tenderness, bony enlargement, and absence of palpable warmth. A patient meeting clinical criteria including knee pain plus three of these features can be classified as having knee osteoarthritis without imaging. However, imaging frequently aids in confirming the diagnosis, assessing severity, excluding other conditions, and planning treatment.

Laboratory studies in osteoarthritis are characteristically normal or show only minimal abnormalities, helping to distinguish the condition from inflammatory arthropathies. Erythrocyte sedimentation rate and C-reactive protein are typically normal or only mildly elevated, unlike the substantial elevations seen in rheumatoid arthritis or crystal arthropathies. Rheumatoid factor and anti-cyclic citrullinated peptide antibodies are negative. Antinuclear antibodies should also be negative. Synovial fluid analysis, when performed, reveals non-inflammatory fluid with white blood cell counts below 2000 per microliter and good mucin clot formation, contrasting with the inflammatory effusions containing tens of thousands of white blood cells seen in gout, pseudogout, or septic arthritis.

Radiographic findings constitute the foundation of imaging diagnosis in osteoarthritis, with four cardinal signs that directly reflect the underlying pathology. Joint space narrowing results from cartilage loss and represents the most direct radiographic indicator of the disease process. Osteophytes appear as marginal bone spurs projecting from joint margins. Subchondral sclerosis manifests as increased bone density directly beneath the joint surface. Subchondral cysts appear as well-defined lucencies within sclerotic bone. These findings may be asymmetric within a joint, reflecting regional variations in cartilage loss. Weight-bearing views are essential for knee radiographs to accurately assess joint space narrowing, as non-weight-bearing films may underestimate cartilage loss.

While plain radiography remains the primary imaging modality, advanced imaging provides additional information in specific circumstances. Magnetic resonance imaging (MRI) detects early cartilage changes before radiographic abnormalities appear, visualizes meniscal and ligamentous pathology, identifies bone marrow edema predicting disease progression, and evaluates soft tissue structures. Computed tomography (CT) provides superior bone detail for complex joint anatomy and surgical planning. Ultrasound permits real-time visualization of effusions, osteophytes, and cartilage abnormalities while facilitating guided injections. These modalities supplement rather than replace plain radiography for routine diagnosis.

<image>Panel A: Plain radiograph of an osteoarthritic knee in weight-bearing view demonstrating the four cardinal radiographic signs: joint space narrowing, marginal osteophytes, subchondral sclerosis, and subchondral cysts (geodes), with each feature labeled. Panel B: Comparison of non-weight-bearing versus weight-bearing knee radiographs showing how weight-bearing views reveal more pronounced joint space narrowing. Panel C: MRI images of early osteoarthritis showing cartilage thinning, bone marrow edema lesions (bright signal), and meniscal pathology not visible on radiographs. Panel D: ACR clinical classification criteria flowchart for knee osteoarthritis showing the pathway from knee pain through age criteria, clinical findings, and diagnosis without imaging requirement.</image>

V. Classification and Staging Systems

The Kellgren-Lawrence grading system represents the most widely used radiographic classification for osteoarthritis severity, providing standardized assessment for clinical practice and research. Grade 0 indicates a radiographically normal joint without features of osteoarthritis. Grade 1 represents doubtful disease with possible subtle joint space narrowing and questionable osteophyte formation. Grade 2 denotes minimal disease with definite osteophytes but possible joint space narrowing. Grade 3 indicates moderate disease with multiple osteophytes, definite joint space narrowing, some sclerosis, and possible bone contour deformity. Grade 4 represents severe disease with large osteophytes, marked joint space narrowing, severe sclerosis, and definite bone contour abnormality. This grading system facilitates communication among clinicians and enables comparison of disease severity across populations.

The Osteoarthritis Research Society International (OARSI) has developed alternative classification systems that separately grade individual radiographic features including joint space width and osteophyte size. Joint space is graded from 0 (normal) to 3 (bone-on-bone contact), while osteophytes are similarly graded by size. This system also incorporates assessment of joint alignment including varus or valgus angulation. The combined structural severity provides a more nuanced characterization than single global scores. These classifications have particular utility in research settings where tracking individual features over time may identify disease progression more sensitively than global assessments.

Functional assessment complements structural evaluation in comprehensively characterizing osteoarthritis impact on patients. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is an osteoarthritis-specific instrument assessing three domains: pain intensity, stiffness severity, and physical function limitations. The Lequesne index provides another validated measure for hip and knee osteoarthritis. The Health Assessment Questionnaire (HAQ) offers a more general measure of disability applicable across rheumatic diseases. The Short Form-36 (SF-36) and similar instruments assess health-related quality of life encompassing physical, emotional, and social dimensions. These patient-reported outcomes capture the disease impact that matters most to patients and frequently guide treatment decisions.

Recognition of distinct disease phenotypes within osteoarthritis has emerged as an important concept with implications for prognosis and potentially treatment selection. Post-traumatic osteoarthritis develops following identifiable joint injury, often presenting at younger ages and potentially progressing more rapidly than idiopathic disease. Metabolic syndrome-associated osteoarthritis relates to obesity, diabetes, and dyslipidemia, with systemic inflammation potentially driving joint pathology beyond mechanical factors. Inflammatory phenotypes featuring prominent synovitis may particularly benefit from anti-inflammatory interventions. Bone-driven phenotypes with predominant subchondral bone changes might respond differently than cartilage-predominant disease. Age-related osteoarthritis with senescent cartilage changes represents another distinct pattern. Phenotype identification may eventually guide personalized treatment approaches.

<image>Panel A: Radiographic examples of Kellgren-Lawrence grades 0 through 4 for knee osteoarthritis, showing progressive changes from normal joint (Grade 0) through questionable changes (Grade 1), definite osteophytes (Grade 2), multiple features with narrowing (Grade 3), to severe end-stage disease (Grade 4). Panel B: WOMAC assessment form showing the three domains of pain (5 items), stiffness (2 items), and physical function (17 items) with Likert scale response options. Panel C: Illustration of osteoarthritis phenotypes comparing post-traumatic (young patient, history of injury), metabolic (obese patient, associated diabetes), inflammatory (prominent synovitis), and age-related (elderly, senescent cartilage) presentations. Panel D: Graph showing imperfect correlation between radiographic severity (Kellgren-Lawrence grade) and patient-reported pain and function scores, illustrating the dissociation between structural and symptomatic disease.</image>

VI. Non-Pharmacologic Management

Patient education forms the cornerstone of osteoarthritis management, empowering individuals to actively participate in their care and set appropriate expectations. Patients should understand that osteoarthritis is a chronic, manageable condition rather than an inevitable consequence of aging requiring resignation. Self-management strategies including activity pacing, joint protection techniques, and recognition of warning signs enable patients to maintain function while avoiding exacerbations. Weight management education is particularly crucial given the strong relationship between obesity and knee osteoarthritis, with each pound of weight loss translating to approximately four pounds of reduced load across the knee with each step. Exercise should be presented as beneficial rather than harmful, countering common misconceptions that activity accelerates joint damage.

Exercise therapy represents one of the most effective interventions for osteoarthritis, providing benefits comparable to analgesic medications without associated risks. Aerobic exercise improves cardiovascular fitness, assists with weight management, and directly benefits joint symptoms through mechanisms that may include enhanced cartilage nutrition and endorphin release. Strengthening exercises targeting muscles supporting affected joints, particularly quadriceps strengthening for knee osteoarthritis and hip abductor strengthening for hip osteoarthritis, reduce joint loading and improve function. Range of motion exercises maintain flexibility and prevent contracture development. Aquatic exercise permits activity with reduced joint loading, making it particularly appropriate for patients with severe symptoms or significant obesity who have difficulty with land-based exercise.

Physical therapy provides structured exercise programs, manual therapy techniques, and education tailored to individual patient needs and capabilities. Joint mobilization by skilled therapists may improve motion and reduce pain through effects on mechanoreceptors and joint capsule. Specific muscle strengthening addresses weakness contributing to abnormal joint mechanics, with quadriceps strengthening being particularly important for knee osteoarthritis. Gait training optimizes walking patterns and introduces appropriate assistive devices. Therapeutic modalities including heat application, cold therapy, transcutaneous electrical nerve stimulation (TENS), and ultrasound may provide symptomatic relief, though evidence for sustained benefit is limited. Physical therapy is most effective when patients continue prescribed exercises independently after formal therapy concludes.

Assistive devices and orthotics reduce joint loading and improve function for patients with osteoarthritis. A cane used in the contralateral hand reduces hip joint loading by approximately 60% during ambulation, significantly decreasing pain and improving walking distance. Walkers provide bilateral support and greater stability for patients with more severe disability or multiple joint involvement. Knee braces designed to unload the affected compartment, such as valgus-producing braces for medial compartment osteoarthritis, can reduce pain and improve function. Shoe inserts including lateral wedge insoles may alter lower extremity alignment and loading patterns, though evidence for efficacy is mixed. Adaptive equipment for activities of daily living, such as raised toilet seats, shower chairs, and jar openers, maintains independence and quality of life.

<image>Panel A: Illustration of weight loss impact on knee joint loading showing that each pound of weight reduction decreases knee load by approximately four pounds per step, with before and after diagrams of joint forces. Panel B: Exercise prescription diagram showing aerobic exercise (walking, swimming, cycling), strengthening exercises (quadriceps sets, straight leg raises, hip abductor exercises), and flexibility exercises (range of motion, stretching) with recommended frequency and duration. Panel C: Proper cane use demonstration showing the cane held in the hand opposite the affected hip or knee, advancing with the affected limb, and load distribution during gait. Panel D: Assistive devices and orthotics including a valgus unloader brace for medial knee osteoarthritis, lateral wedge insole, and adaptive equipment for daily activities.</image>

VII. Pharmacologic Management

First-line pharmacologic options for osteoarthritis provide symptomatic relief while carrying varying safety profiles that influence agent selection based on individual patient characteristics. Acetaminophen has historically been recommended as initial therapy due to its favorable safety profile, though recent evidence suggests only modest efficacy for osteoarthritis pain, and hepatotoxicity risk necessitates attention to dosing limits (maximum 3 grams daily in most patients) and avoidance in patients with liver disease. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) provide local pain relief for knee and hand osteoarthritis with minimal systemic exposure, making them particularly appropriate for elderly patients or those with comorbidities precluding oral NSAIDs. Oral NSAIDs demonstrate superior efficacy to acetaminophen but carry gastrointestinal, cardiovascular, and renal risks requiring careful patient selection. Duloxetine, a serotonin-norepinephrine reuptake inhibitor, provides analgesia through central pain modulation and may be particularly useful when chronic pain syndrome features are prominent.

Nonsteroidal anti-inflammatory drug selection and monitoring requires attention to individual risk factors and potential drug interactions. Gastrointestinal risk can be mitigated by co-prescribing proton pump inhibitors or selecting COX-2 selective NSAIDs, which spare cyclooxygenase-1 mediated gastroprotection while maintaining anti-inflammatory efficacy. Cardiovascular risk assessment should precede NSAID prescription, with avoidance in patients with established cardiovascular disease; among available agents, naproxen appears to have the most favorable cardiovascular safety profile. Renal function monitoring is essential, and NSAIDs should be avoided or used with extreme caution in patients with chronic kidney disease. The treatment principle of using the lowest effective dose for the shortest necessary duration applies to minimize cumulative toxicity.

Intra-articular injections offer targeted therapy delivering medication directly to the affected joint. Corticosteroid injections provide rapid, though typically temporary, relief lasting weeks to months, and are particularly useful for acute flares or when systemic therapy is contraindicated. Limiting injection frequency to three to four times annually per joint is generally recommended due to concerns about potential acceleration of cartilage loss with frequent injections, though evidence remains somewhat conflicting. Hyaluronic acid injections aim to restore viscoelastic properties of synovial fluid, with modest benefit demonstrated in some studies though enthusiasm has waned given variable response and multiple injection requirements. Platelet-rich plasma and stem cell injections remain investigational with insufficient evidence to support routine use outside of clinical trials.

Additional pharmacologic options serve specific roles in osteoarthritis management. Glucosamine and chondroitin sulfate are widely used supplements with minimal adverse effects, though clinical trial evidence demonstrates at best modest benefit, and they may be attempted in patients wishing to try complementary approaches. Topical capsaicin depletes substance P from nerve terminals and may provide modest pain relief with repeated application. Tramadol offers opioid-like analgesia without full opioid receptor agonism and may be considered when other options prove inadequate, though abuse potential and side effects limit its role. Strong opioids should be reserved as last-line agents given risks of dependence, adverse effects, and limited evidence for long-term efficacy in chronic non-cancer pain; they are generally inappropriate except for patients who have failed or are not candidates for other treatments and surgical intervention.

<image>Panel A: Pharmacologic treatment algorithm for osteoarthritis beginning with topical NSAIDs and acetaminophen as first-line, advancing to oral NSAIDs, intra-articular injections, and duloxetine, with tramadol reserved for refractory cases. Panel B: Risk stratification table for oral NSAID use considering gastrointestinal risk factors (history of ulcer, age, anticoagulant use), cardiovascular risk factors (coronary disease, heart failure), and renal risk factors (CKD, diuretic use), with recommendations for each scenario. Panel C: Intra-articular injection technique showing needle entry sites for knee joint (superolateral, medial), aspiration of effusion, and corticosteroid injection. Panel D: Comparison of injection therapies including corticosteroids (rapid onset, temporary benefit), hyaluronic acid (delayed onset, possibly longer duration), and investigational options (PRP, stem cells) with efficacy evidence and typical protocols.</image>

VIII. Surgical Management

Surgical intervention becomes appropriate when conservative management has been adequately attempted without achieving satisfactory pain relief or function, and the patient is an appropriate surgical candidate with realistic expectations. The determination that conservative treatment has failed generally requires an adequate trial of three to six months including pharmacologic therapy and physical therapy or exercise program. Pain severity sufficient to significantly affect quality of life, including sleep disturbance, activity limitation, and emotional impact, supports surgical consideration. Functional impairment preventing activities important to the patient, such as walking, climbing stairs, or participating in social activities, similarly justifies surgical evaluation. Radiographic severity alone does not dictate surgical timing, as symptoms and function are paramount; however, patients with severe structural disease typically derive greater benefit from joint replacement.

Several surgical procedures address osteoarthritis depending on disease severity, joint involved, patient age, and activity demands. Arthroscopy plays a limited role in osteoarthritis management; while debridement of meniscal tears and loose body removal may provide some benefit, arthroscopic lavage and debridement for osteoarthritis generally produces results no better than sham surgery and is not recommended for osteoarthritis alone. Osteotomy, involving surgical cutting and realignment of bone, redistributes load away from the damaged compartment and may postpone need for joint replacement in younger patients with unicompartmental disease; high tibial osteotomy for varus knee malalignment represents the most common application. Arthrodesis (joint fusion) sacrifices motion to eliminate pain and provides a salvage option for joints where replacement is not feasible, such as the ankle in some situations or following failed arthroplasty. Resection arthroplasty removes damaged joint surfaces without prosthetic replacement and serves as a salvage procedure.

Total joint replacement (arthroplasty) represents the definitive surgical treatment for end-stage osteoarthritis, with excellent outcomes for appropriately selected patients. Total knee arthroplasty is the most commonly performed joint replacement, with over 700,000 procedures annually in the United States. Total hip arthroplasty demonstrates even higher patient satisfaction and functional improvement. Unicompartmental (partial) knee replacement may be appropriate when only one knee compartment is affected, preserving more bone and allowing more natural kinematics. Shoulder and other joint replacements are performed less frequently but provide significant benefit for appropriate indications. Modern prostheses demonstrate excellent longevity, with 90% or more functioning well at 15-20 years, though younger, more active patients may eventually require revision surgery.

Postoperative management and realistic expectations are essential for successful surgical outcomes. Deep venous thrombosis prophylaxis with anticoagulation and compression devices reduces the substantial thromboembolic risk following lower extremity joint replacement. Physical therapy beginning immediately postoperatively promotes early mobilization, strength recovery, and optimal functional outcomes. Potential complications include infection, which may require prosthesis removal; loosening requiring revision surgery; dislocation, particularly following hip replacement; and persistent stiffness or instability. Most patients achieve excellent pain relief and improved function, with approximately 90% satisfaction rates for total hip and knee replacement. However, 10-20% of patients have persistent pain or dissatisfaction, making careful patient selection and expectation management crucial.

<image>Panel A: Indications for surgical referral flowchart showing the pathway from inadequate response to conservative treatment through pain and functional assessment to surgical consultation, with appropriate candidacy factors. Panel B: Surgical options comparison showing arthroscopy (limited role, debridement), osteotomy (realignment for younger patients with unicompartmental disease), and total joint replacement (definitive treatment for end-stage disease). Panel C: Total knee and total hip replacement component diagrams showing femoral, tibial, and patellar components for knee and acetabular and femoral components for hip, with prosthesis positioning within the joint. Panel D: Postoperative rehabilitation timeline showing immediate mobilization, progression through walking aids, physical therapy milestones, and expected return to activities at various timepoints following total joint replacement.</image>

IX. Site-Specific Considerations

Hip osteoarthritis presents distinctive features that influence its recognition and management. Pain typically localizes to the groin and anterior thigh rather than the lateral hip, though buttock and even knee pain may occur through referred patterns, sometimes delaying correct diagnosis. Physical examination reveals characteristic restriction of internal rotation early in the disease course, along with limitation of flexion and other motions as severity increases. The Trendelenburg gait, with dropping of the pelvis on the unsupported side during stance phase, reflects abductor muscle weakness. Differential diagnosis includes greater trochanteric bursitis, which presents with lateral hip pain directly over the trochanter, and lumbar spine pathology, which may cause buttock and posterior thigh symptoms. Total hip arthroplasty is among the most successful orthopedic procedures, with predictable pain relief and functional improvement.

Hand osteoarthritis encompasses several patterns with distinct features and management approaches. Nodal osteoarthritis, characterized by Heberden and Bouchard nodes at the distal and proximal interphalangeal joints respectively, is the most common form and predominantly affects women. First carpometacarpal (thumb base) osteoarthritis produces pain with pinching and gripping activities, weakness, and the characteristic squared appearance of the thumb base. Erosive inflammatory osteoarthritis, a more aggressive variant, features prominent inflammation, central erosions on radiographs, and a more destructive course than typical hand osteoarthritis. Management emphasizes hand therapy, splinting (particularly for first CMC involvement), topical NSAIDs (which are particularly appropriate given superficial location), and intra-articular injections. Surgical options include joint fusion for painful interphalangeal joints and trapeziectomy or arthroplasty for severe first CMC disease.

Spinal osteoarthritis affects facet joints in the posterior spinal column and commonly accompanies disc degeneration, together termed spondylosis or degenerative disc disease. Cervical and lumbar regions are most frequently involved, with thoracic spine typically spared. Facet joint osteoarthritis contributes to axial pain, while associated changes including disc bulging, ligamentum flavum hypertrophy, and osteophyte formation may produce spinal stenosis with neurogenic claudication (pain with walking relieved by forward flexion) or radiculopathy. Initial management follows conservative principles including physical therapy, analgesics, and activity modification. Facet joint or epidural steroid injections may provide temporary relief. Surgical decompression is reserved for patients with significant neurological symptoms or stenosis refractory to conservative management, with fusion added when instability is present.

Osteoarthritis in younger patients presents unique challenges warranting distinct management approaches. Investigation for secondary causes is essential, as metabolic, inflammatory, or anatomic abnormalities may be amenable to specific treatment. Joint preservation strategies take priority over joint replacement given prosthesis longevity limitations and higher activity demands. Osteotomy may delay the need for arthroplasty by redistributing load away from damaged areas. Cartilage repair techniques including microfracture, osteochondral grafting, and matrix-assisted autologous chondrocyte implantation (MACI) may address focal cartilage defects, though their role in established osteoarthritis is limited. Activity modification avoiding high-impact activities protects joints while maintaining fitness through lower-impact alternatives. When joint replacement becomes necessary, younger patients should understand the likelihood of eventual revision surgery given their greater life expectancy.

<image>Panel A: Hip osteoarthritis clinical features showing groin pain location, limited internal rotation on examination, and Trendelenburg gait pattern with compensatory trunk lean. Panel B: Hand osteoarthritis patterns comparing nodal osteoarthritis (Heberden and Bouchard nodes), first CMC osteoarthritis (squared thumb base, pain with pinching), and erosive osteoarthritis (central erosions, inflammatory features). Panel C: Spinal osteoarthritis anatomy showing facet joint arthritis, disc degeneration, osteophyte formation, and spinal stenosis with nerve root compression in cross-sectional and sagittal views. Panel D: Young patient management approach highlighting investigation for secondary causes, joint preservation strategies (osteotomy, cartilage repair), activity modification, and eventual consideration of joint replacement with revision expectation.</image>

X. Prevention and Future Directions

Prevention strategies for osteoarthritis target modifiable risk factors, with weight control and injury prevention offering the most substantial potential impact. Maintaining healthy body weight reduces the mechanical load on weight-bearing joints while also decreasing systemic inflammation from adipose tissue that may contribute to cartilage degradation. Weight loss in overweight individuals demonstrably reduces the incidence of knee osteoarthritis and slows progression in established disease. Injury prevention through proper training techniques, appropriate protective equipment, and optimization of playing surfaces reduces sports-related joint injuries that frequently lead to post-traumatic osteoarthritis. Anterior cruciate ligament reconstruction aims to restore knee stability and potentially reduce subsequent osteoarthritis, though post-traumatic arthritis often develops despite successful surgery. Occupational modifications reducing repetitive joint stress may prevent occupation-related osteoarthritis.

Disease-modifying osteoarthritis drugs (DMOADs) represent a major unmet need, as no currently approved therapies alter the structural progression of disease. Unlike rheumatoid arthritis, where disease-modifying agents have revolutionized outcomes, osteoarthritis lacks treatments that prevent cartilage loss or promote regeneration. This gap reflects the complex multifactorial pathophysiology, the slow disease course requiring prolonged trials, and the challenges of developing reliable biomarkers to assess treatment effects. Cartilage repair strategies including microfracture (which stimulates fibrocartilage formation through controlled injury to subchondral bone), osteochondral autograft or allograft transplantation, and matrix-assisted autologous chondrocyte implantation (MACI) address focal defects but do not reverse established generalized osteoarthritis. Gene therapy approaches remain in early preclinical development.

Emerging therapeutic approaches in clinical development target specific pathways implicated in osteoarthritis pathophysiology. Interleukin-1 inhibitors aim to block a key catabolic cytokine, though clinical trials have not demonstrated significant efficacy to date. Matrix metalloproteinase inhibitors that prevent collagen and proteoglycan degradation have shown promise preclinically but have been limited by musculoskeletal side effects in clinical trials. Nerve growth factor inhibitors targeting anti-NGF antibodies provide potent analgesia through a novel mechanism, but concerns about rapidly progressive osteoarthritis in a subset of patients have complicated development. Wnt pathway modulators may influence both bone and cartilage homeostasis. Senolytic agents targeting senescent cells in osteoarthritic joints represent a novel approach in early investigation.

Biomarker development promises to improve osteoarthritis diagnosis, prognosis, and treatment monitoring. Molecular biomarkers reflecting cartilage turnover include CTX-II, a collagen degradation product measured in urine, and COMP (cartilage oligomeric matrix protein) in serum, which correlate with disease activity and progression in some studies. Hyaluronic acid levels reflect synovial inflammation. These markers may identify patients at risk for rapid progression or most likely to respond to specific interventions. Imaging biomarkers including MRI assessment of cartilage volume, composition (through T2 mapping and delayed gadolinium-enhanced MRI), and bone marrow lesions provide structural information beyond plain radiographs. Integration of clinical, molecular, and imaging biomarkers into composite indices may enable earlier diagnosis and more precise treatment selection, potentially facilitating development and testing of disease-modifying therapies.

<image>Panel A: Prevention strategies diagram showing weight management (BMI goal, caloric balance), injury prevention (proper training, protective equipment, ACL reconstruction after injury), exercise (moderate activity protective, high-impact concerning), and occupational modification (ergonomics, job rotation). Panel B: Disease-modifying therapy development pipeline showing failed or abandoned approaches (MMP inhibitors, early IL-1 inhibitors), cautiously advancing therapies (anti-NGF requiring monitoring), and emerging approaches (Wnt modulators, senolytics). Panel C: Cartilage repair techniques comparing microfracture (fibrocartilage formation), osteochondral autograft (plug transfer), and MACI (chondrocyte expansion and implantation) with appropriate indications and limitations. Panel D: Biomarker applications in osteoarthritis showing molecular markers (CTX-II, COMP, hyaluronic acid) reflecting cartilage degradation and synovial inflammation, and MRI biomarkers (cartilage volume and composition, bone marrow lesions) enabling quantitative structural assessment.</image>

Summary

• Osteoarthritis is the most common form of arthritis, characterized by progressive cartilage loss with secondary bone and synovial changes
• Risk factors include age (strongest), obesity (most important modifiable), prior joint injury, female sex, genetics, and occupational joint stress
• Pathophysiology involves proteoglycan loss, collagen network disruption, chondrocyte dysfunction, and imbalance between catabolic and anabolic processes
• Clinical presentation features activity-related pain, morning stiffness lasting less than 30 minutes, bony enlargement, crepitus, and characteristic joint distribution
• Radiographic cardinal signs are joint space narrowing, osteophytes, subchondral sclerosis, and subchondral cysts; weight-bearing views are essential
• Non-pharmacologic management includes patient education, weight loss, exercise, physical therapy, and assistive devices
• Pharmacologic options include topical and oral NSAIDs, acetaminophen, intra-articular corticosteroids, and hyaluronic acid; duloxetine addresses central sensitization
• Total joint replacement provides excellent outcomes for end-stage disease, with over 90% patient satisfaction for hip and knee arthroplasty
• No disease-modifying treatments are currently approved; development of DMOADs remains a major unmet need

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown